Over 12 months, OneMedNet Corp saw more buying than selling from its insiders — purchases of about $4.2 million against sales of $321,000.
Biggest single buyer: Yu Jeffrey, Executive Officer, with roughly $750,000. C-suite participation is part of the picture here.
22 investment managers listed ONMD in their latest 13F filings (Q2 2026); more funds bought than sold. Last full quarter: net selling by insiders. Insiders bought in 5 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Golden Robert Lawrence | CFO | Sell | 2,500 | $6.60 | $16K | SEC |
| Oct 9, 2026 | Green Aaron | CEO | Sell | 5,000 | $7.39 | $37K | SEC |
| Oct 9, 2026 | Green Aaron | CEO | Sell | 1,667 | $6.48 | $11K | SEC |
| Oct 9, 2026 | Golden Robert Lawrence | CFO | Sell | 3,000 | $6.30 | $19K | SEC |
| Oct 9, 2026 | Golden Robert Lawrence | CFO | Sell | 3,000 | $6.63 | $20K | SEC |
| Jun 24, 2026 | Green Aaron | CEO | Buy | 36,650 | $0.57 | $21K | SEC |
| Jun 24, 2026 | Yu Jeffrey | Executive Officer | Buy | 158,730 | $0.63 | $100K | SEC |
| Jun 17, 2026 | Yu Jeffrey | Executive Officer | Buy | 172,414 | $0.58 | $100K | SEC |
| Jun 16, 2026 | Green Aaron | CEO | Buy | 18,702 | $0.54 | $10K | SEC |
| Jun 16, 2026 | Green Aaron | CEO | Buy | 36,920 | $0.56 | $21K | SEC |
| Jun 15, 2026 | Kosasa Thomas | Director | Buy | 158,730 | $0.63 | $100K | SEC |
| May 20, 2026 | Kosasa Thomas | Director | Buy | 268,817 | $0.93 | $250K | SEC |
| Apr 24, 2026 | Yu Jeffrey | Executive Officer | Buy | 903,614 | $0.83 | $750K | SEC |
| Apr 24, 2026 | Kosasa Thomas | Director | Buy | 595,238 | $0.84 | $500K | SEC |
| Apr 24, 2026 | Kosasa Thomas | Director | Buy | 280,898 | $0.89 | $250K | SEC |
In the last 12 months OneMedNet Corp insiders made open-market purchases worth about $4.2 million and sales worth about $321,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ONMD was filed on 2026-10-09.
22 investment managers reported holding ONMD in SEC Form 13F filings for Q2 2026.
No congressional trades in ONMD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).